目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Type Segment
1.1.2. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objective

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increase in adoption of next-generation sequencing
3.2.1.2. Growing R&D in proteomics and genomics
3.2.1.3. Presence of an extensive drug-development pipeline
3.2.1.4. Increasing adoption of personalized medicine
3.2.1.5. Rapid technological advances in biochip technology
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of manufacturing
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Group Business Analysis
4.1. Type Segment Dashboard
4.2. Biochip Market Type Movement Analysis
4.3. Biochip Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. DNA Chips
4.4.1. DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. Cancer Diagnosis and Treatment
4.4.2.1. Cancer diagnosis and treatment market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Gene Expression
4.4.3.1. Gene expression market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. SNP Genotyping
4.4.4.1. SNP genotyping market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.5. Genomics
4.4.5.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.6. Drug Discovery
4.4.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.7. Agricultural Biotechnology
4.4.7.1. Agricultural biotechnology market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.8. Others
4.4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Protein Chips
4.5.1. Protein chips market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2. Proteomics
4.5.2.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Expression Profiling
4.5.3.1. Expression profiling market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.4. Diagnostics
4.5.4.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.5. HTS
4.5.5.1. HTS market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.6. Drug Discovery
4.5.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.7. Others
4.5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Lab-on-chip
4.6.1. Lab-on-chip market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.2. Genomics
4.6.2.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.3. IVD & POC
4.6.3.1. IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.4. Proteomics
4.6.4.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.5. Drug Discovery
4.6.5.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.6. Others
4.6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Tissue Arrays
4.7.1. Tissue arrays market estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Cell Arrays
4.8.1. Cell arrays market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis
5.1. End Use Segment Dashboard
5.2. Biochip Market End Use Movement Analysis
5.3. Biochip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Biotechnology & Pharmaceutical Companies
5.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Hospitals & Diagnostic Centers
5.5.1. Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Academic & Research Institute
5.6.1. Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis by Type, End Use
6.1. Regional Dashboard
6.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
6.3. North America
6.3.1. North America Biochip Market, 2018 - 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Target Disease Prevalence
6.3.2.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Target Disease Prevalence
6.3.3.4. Canada Biochip Market, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Target Disease Prevalence
6.3.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Biochip Market, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Target Disease Prevalence
6.4.2.4. UK Biochip Market, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Target Disease Prevalence
6.4.3.4. Germany Biochip Market, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Target Disease Prevalence
6.4.4.4. France Biochip Market, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Target Disease Prevalence
6.4.5.4. Italy Biochip Market, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Target Disease Prevalence
6.4.6.4. Spain Biochip Market, 2018 - 2030 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Denmark Biochip Market, 2018 - 2030 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Target Disease Prevalence
6.4.8.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Target Disease Prevalence
6.4.9.4. Norway Biochip Market, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Japan Biochip Market, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. China Biochip Market, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Target Disease Prevalence
6.5.4.4. India Biochip Market, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Target Disease Prevalence
6.5.5.4. Australia Biochip Market, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Target Disease Prevalence
6.5.6.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Target Disease Prevalence
6.5.7.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Biochip Market, 2018 - 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Target Disease Prevalence
6.6.2.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Target Disease Prevalence
6.6.3.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. MEA Biochip Market, 2018 - 2030 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Target Disease Prevalence
6.7.2.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Target Disease Prevalence
6.7.3.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Target Disease Prevalence
6.7.4.4. UAE Biochip Market, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Target Disease Prevalence
6.7.5.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. Agilent Technologies
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. PerkinElmer, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Illumina, Inc.
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Bio-Rad Laboratories, Inc.
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Standard BioTools Inc.
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. GE HealthCare
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. IBIOCHIPS
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. LI-COR, Inc.
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Cellix Ltd
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Randox Laboratories Ltd.
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives

List of Tables
Table 1 List of abbreviation
Table 2 Global biochip market, by region, 2018 - 2030 (USD Million)
Table 3 Global biochip market, by type, 2018 - 2030 (USD Million)
Table 4 Global biochip market, by end use, 2018 - 2030 (USD Million)
Table 5 North America biochip market, by country, 2018 - 2030 (USD Million)
Table 6 North America biochip market, by type, 2018 - 2030 (USD Million)
Table 7 North America biochip market, by end use, 2018 - 2030 (USD Million)
Table 8 U.S. biochip market, by type, 2018 - 2030 (USD Million)
Table 9 U.S. biochip market, by end use, 2018 - 2030 (USD Million)
Table 10 Canada biochip market, by type, 2018 - 2030 (USD Million)
Table 11 Canada biochip market, by end use, 2018 - 2030 (USD Million)
Table 12 Mexico biochip market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico biochip market, by end use, 2018 - 2030 (USD Million)
Table 14 Europe biochip market, by country, 2018 - 2030 (USD Million)
Table 15 Europe biochip market, by type, 2018 - 2030 (USD Million)
Table 16 Europe biochip market, by end use, 2018 - 2030 (USD Million)
Table 17 Germany biochip market, by type, 2018 - 2030 (USD Million)
Table 18 Germany biochip market, by end use, 2018 - 2030 (USD Million)
Table 19 UK biochip market, by type, 2018 - 2030 (USD Million)
Table 20 UK biochip market, by end use, 2018 - 2030 (USD Million)
Table 21 France biochip market, by type, 2018 - 2030 (USD Million)
Table 22 France biochip market, by end use, 2018 - 2030 (USD Million)
Table 23 Italy biochip market, by type, 2018 - 2030 (USD Million)
Table 24 Italy biochip market, by end use, 2018 - 2030 (USD Million)
Table 25 Spain biochip market, by type, 2018 - 2030 (USD Million)
Table 26 Spain biochip market, by end use, 2018 - 2030 (USD Million)
Table 27 Denmark biochip market, by type, 2018 - 2030 (USD Million)
Table 28 Denmark biochip market, by end use, 2018 - 2030 (USD Million)
Table 29 Sweden biochip market, by type, 2018 - 2030 (USD Million)
Table 30 Sweden biochip market, by end use, 2018 - 2030 (USD Million)
Table 31 Norway biochip market, by type, 2018 - 2030 (USD Million)
Table 32 Norway biochip market, by end use, 2018 - 2030 (USD Million)
Table 33 Asia Pacific biochip market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific biochip market, by type, 2018 - 2030 (USD Million)
Table 35 Asia Pacific biochip market, by end use, 2018 - 2030 (USD Million)
Table 36 China biochip market, by type, 2018 - 2030 (USD Million)
Table 37 China biochip market, by end use, 2018 - 2030 (USD Million)
Table 38 Japan biochip market, by type, 2018 - 2030 (USD Million)
Table 39 Japan biochip market, by end use, 2018 - 2030 (USD Million)
Table 40 India biochip market, by type, 2018 - 2030 (USD Million)
Table 41 India biochip market, by end use, 2018 - 2030 (USD Million)
Table 42 South Korea biochip market, by type, 2018 - 2030 (USD Million)
Table 43 South Korea biochip market, by end use, 2018 - 2030 (USD Million)
Table 44 Australia biochip market, by type, 2018 - 2030 (USD Million)
Table 45 Australia biochip market, by end use, 2018 - 2030 (USD Million)
Table 46 Thailand biochip market, by type, 2018 - 2030 (USD Million)
Table 47 Thailand biochip market, by end use, 2018 - 2030 (USD Million)
Table 48 Latin America biochip market, by country, 2018 - 2030 (USD Million)
Table 49 Latin America biochip market, by type, 2018 - 2030 (USD Million)
Table 50 Latin America biochip market, by end use, 2018 - 2030 (USD Million)
Table 51 Brazil biochip market, by type, 2018 - 2030 (USD Million)
Table 52 Brazil biochip market, by end use, 2018 - 2030 (USD Million)
Table 53 Argentina biochip market, by type, 2018 - 2030 (USD Million)
Table 54 Argentina biochip market, by end use, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa biochip market, by country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa biochip market, by type, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa biochip market, by end use, 2018 - 2030 (USD Million)
Table 58 South Africa biochip market, by type, 2018 - 2030 (USD Million)
Table 59 South Africa biochip market, by end use, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia biochip market, by type, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia biochip market, by end use, 2018 - 2030 (USD Million)
Table 62 UAE biochip market, by type, 2018 - 2030 (USD Million)
Table 63 UAE biochip market, by end use, 2018 - 2030 (USD Million)
Table 64 Kuwait biochip market, by type, 2018 - 2030 (USD Million)
Table 65 Kuwait biochip market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Biochip market: market outlook
Fig. 7 Biochip competitive insights
Fig. 8 Parent market outlook
Fig. 9 Biochip market driver impact
Fig. 10 Biochip market restraint impact
Fig. 11 Biochip market: Type movement analysis
Fig. 12 Biochip market: Type outlook and key takeaways
Fig. 13 DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Cancer diagnostics & treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Gene expression market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 16 SNP genotyping market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 17 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Agricultural biotechnology market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 21 Protein chips market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 23 Expression profiling market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 24 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 HTS market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 28 Lab-on-chip market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 29 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 32 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Biochip market: End use movement analysis
Fig. 35 Biochip market: End use outlook and key takeaways
Fig. 36 Biotechnology & pharmaceutical companies market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 37 Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 North America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 U.S. biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Canada biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Mexico biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Europe biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 UK biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 France biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Italy biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Spain biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Denmark biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Sweden biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Norway biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 China biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Japan biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 India biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Thailand biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Korea biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Australia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Latin America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Brazil biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Argentina biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Middle East and Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 South Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 UAE biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Kuwait biochip market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Market share of key market players - Biochip market